CURRICULUM VITAE

DAVID A. KHAN, MD

University of Texas Southwestern Medical Center 5323 Harry Hines Boulevard Dallas, TX 75390-8859 (214) 648-5659 (work) (214) 648-9102 (fax) [email protected]

EDUCATION 1980 -1984 University of Illinois, Champaign IL; B.S. in Chemistry, Magna Cum Laude 1984 -1988 University of Illinois School of Medicine, Chicago IL; M.D. 1988 -1991 Good Samaritan Medical Center, Phoenix AZ; Internal Medicine internship & residency 1991-1994 Mayo Clinic, Rochester MN; & fellowship

PROFESSIONAL EXPERIENCE 1994 -2001 Assistant Professor of Internal Medicine, UT Southwestern 1997 -1998 Co-Director, Allergy & Immunology Training Program 1998 - Director, Allergy & Immunology Training Program 2002- 2008 Associate Professor of Internal Medicine, UT Southwestern 2008-present Professor of Medicine, UT Southwestern

AWARDS/HONORS 1993 Allen & Hanburys Respiratory Institute Allergy Fellowship Award 1993 Von Pirquet Award 2001 Outstanding Teacher 2000-2001 UTSW Class of 2003 2004 Outstanding Teacher 2003-2004 UTSW Class of 2006 2005 Outstanding Teacher 2004-2005 UTSW Class of 2007 2006 Daniel Goodman Lectureship, ACAAI meeting 2007 Most Entertaining Teacher 2006-2007 UTSW Class of 2009 2008 Stanislaus Jaros Lectureship, ACAAI meeting 2009 Outstanding Teacher 2007-2008 UTSW Class of 2010 2011 John L. McGovern Lectureship, ACAAI meeting 2012 I. Leonard Bernstein Lecture, ACAAI meeting 2014 Distinguished Fellow, ACAAI meeting 2015 Elliot F. Ellis Memorial Lectureship, AAAAI meeting 2015 Bernard Berman Lectureship, ACAAI meeting 2015 Norman A. Sterrie Lectureship 2016 Outstanding Teacher 2016-2017 UTSW Class of 2019 2017 Distinguished Clinician Award, AAAAI meeting 2019 Outstanding Teacher 2018-2019 UTSW Class of 2022 2019 Outstanding Teacher 2019-2020 UTSW Class of 2022

David Khan, MD CV page 1 BOARD CERTIFICATIONS 1991 American Board of Internal Medicine 1993, 2003, 2013 American Board of Allergy & Immunology

PROFESSIONAL SOCIETY MEMBERSHIPS 1993 Fellow, American Academy of Allergy, and Immunology 1993 Fellow, American College of Allergy, Asthma and Immunology 1993-2006 Member, American Thoracic Society 1998 Texas Allergy, Asthma & Immunology Society

REGIONAL/NATIONAL ADMINISTRATIVE POSITIONS 2000-2012 Director, Parkland Memorial Hospital Asthma Clinic 2002-2006 Director, Internal Medicine Subspecialty Clinic, Aston Ambulatory Care Center 2002-2004 Secretary-Treasurer, Texas Allergy, Asthma, and Immunology Society 2002-2006 Board of Trustees, Education & Research Trust Fund, AAAAI 2002-2006 2003-2019 Joint Task Force on Practice Parameters for Allergy & Immunology 2004-2006 Pharmaceutical Symposium Committee, Vice-Chair 2004-2006, ACAAI 2004-2006 President-Elect, Texas Allergy, Asthma, and Immunology Society 2005-2006 In-Training Exam Subcommittee (Team leader), AAAAI 2005-2007 FADDA Workshops Representative 2005-2007, AAAAI 2006-2008 President, Texas Allergy, Asthma, and Immunology Society 2006-2007 Vice-chair, In-Training Exam Subcommittee, AAAAI 2007-2009 Vice-chair, ART Resource Development Committee 2007-2014 Chair, Allied Health Committee, ACAAI 2007-2009 Co-chair, Conjoint Board Review Committee, ACAAI/AAAAI 2007-2009 Chair, In-Training Exam Subcommittee, AAAAI 2007-2010 Training Program Directors Planning Committee, ACAAI 2007-2008 Nominating Committee, ACAAI 2008-2010 Chair, and Anaphylaxis Committee, ACAAI 2008-2010 Past-President, Texas Allergy, Asthma, and Immunology Society 2009-2010 Chair, Allergy and Anaphylaxis Committee, ACAAI 2009-2011 Secretary, FADDA interest section, AAAAI 2011-2013 Vice-Chair, FADDA interest section, AAAAI 2012-2018 Co-chair, Conjoint Board Review Committee, ACAAI/AAAAI 2013-2015 Chair, FADDA interest section, AAAAI 2013-2015 Program Directors Assembly Executive Committee, AAAAI 2016-2020 Board of Directors, AAAAI 2018-2020 Vice Chair, Program Directors Assembly 2018-2019 Vice Chair, Advocacy Committee 2018-2020 Chair, Practice and Policy Division 2019-2020 Chair, Advocacy Committee 2020-2021 Chair, Program Directors Assembly 2020-2021 Secretary/Treasurer AAAAI

David Khan, MD CV page 2 EDITORIAL BOARDS 2012-2018 JACI In Practice, Editorial Board member 2018-present JACI In Practice, Associate Editor 2012-2019 Journal of Asthma, Editorial Board member 2013-present Allergy Watch, Editorial Board member

JOURNAL REVIEWER 2000-current Annals of Alllergy, Asthma, Immunology; ad-hoc reviewer 2000-current JACI; ad hoc reviewer 2008-current Allergy, Asthma Proceedings, ad hoc reviewer

David Khan, MD CV page 3 Investigator Initiated Research Experience

1996 -1998 Co-Investigator, NARSAD (Affective symptoms from : a hypothesis for bipolar disorder) 1998 - 2000 Principal Investigator, TAAIS (Effect of a 5-lipoxygenase inhibitor on nasal polyposis) 1998-2000 Co-Investigator, NARSAD (Hippocampal Changes During Chronic Exposure) 1999- 2002 Principal Investigator, Merck (Effectiveness of montelukast in a primary care managed population of inner city children with asthma) 2000- 2005 Co-Investigator, NIMH (Hippocampal Function During Corticosteroid Therapy) 2001- 2004 Co-Investigator, NIMH (Treating asthma patients with major depressive disorder) 2001 - 2002 Principal Investigator, (Efficacy of a proton pump inhibitor in asymptomatic gastroesophageal reflux) 2002 - 2003 Principal Investigator, GCRC (Efficacy of dapsone in chronic idiopathic urticaria) 2002-2004 Principal Investigator, TAAIS (Prevalence of local IgE to dust mites in “non-allergic ) 2002-2004 Principal Investigator, (Prevention of with topical nasal corticosteroids) 2004-2007 Principal Investigator, (Effect of Esomeprazole on Non- in patients with symptoms of gastric reflux) 2005-2008 Principal Investigator, Gene expression and cytokine changes with Rush Immunotherapy 2006-2007 Principal Investigator, Randomized, Double Blind, Placebo- Controlled, Multicenter Study of a Subcutaneous Formulation of Icatibant for the Treatment of Hereditary 2007-2015 Principal Investigator, Safety of Aspirin Desensitization using a 1 hr dose escalation protocol 2007-2009 Principal Investigator, Development and validation of an allergic rhinitis questionnaire to measure symptom severity 2007-2016 Principal Investigator, Safety of Rush Immunotherapy with multiple allergens using a modified protocol 2009-2012 Principal Investigator, Safety of Oral Drug Challenges 2009-2016 Principal Investigator, Safety and Efficacy of Tacrolimus in refractory chronic urticaria 2010-2015 Co-Investigator, NHLBI, Antidepressant Treatment at an Inner City Asthma Clinic 2010-2015 Co-Investigator, NIH, Reversing Corticosteroid-Induced Memory Impairment 2010-2015 Co-Investigator, Attenuation of Corticosteroid-Induced Hippocampal Changes 2014-present Principal Investigator, Inpatient Penicillin Allergy Evaluation with Pharmacists 2015-2019 Co-Investigator, NIH, Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators 2018-2022 Co-Investigator, NHLBI, Dallas Asthma Brain and Cognition Study 2019-2020 Principal Investigator, NIAID, Determining the Accuracy of Cephalosporin Allergy Testing

David Khan, MD CV page 4 PUBLICATIONS

Peer Reviewed Publications 1. Yocum MW, Khan DA, Van Dellen RG, Jiang NS. Ambophyllin, an office-dispensed tablet for asthma, contains triamcinolone. J Allergy Clin Immunol. 1992;90(1):127-9. 2. Khan DA, Yocum MW. Clinical course of idiopathic anaphylaxis. Ann Allergy. 1994;73(4):370-4. 3. Yocum MW, Khan DA. Assessment of patients who have experienced anaphylaxis: a 3- year survey. Mayo Clin Proc. 1994;69(1):16-23. 4. Brown ES, Khan DA, Nejtek VA. The psychiatric side effects of corticosteroids. Ann Allergy Asthma Immunol. 1999;83(6 Pt 1):495-503; quiz -4. 5. Brown ES, Khan DA, Suppes T. Treatment of corticosteroid-induced mood changes with olanzapine. Am J Psychiatry. 1999;156(6):968. 6. Brown ES, Bauer MS, Suppes T, Khan DA, Carmody T. Comparison of the internal state scale to clinician-administered scales in asthma patients receiving corticosteroid therapy. Gen Hosp Psychiatry. 2000;22(3):180-3. 7. Brown ES, Khan DA, Mahadi S. Psychiatric diagnoses in inner city outpatients with moderate to severe asthma. Int J Psychiatry Med. 2000;30(4):319-27. 8. Khan DA, Cody DT, 2nd, George TJ, Gleich GJ, Leiferman KM. Allergic fungal : an immunohistologic analysis. J Allergy Clin Immunol. 2000;106(6):1096-101. 9. Zielinski TA, Brown ES, Nejtek VA, Khan DA, Moore JJ, Rush AJ. Depression in Asthma: Prevalence and Clinical Implications. Prim Care Companion J Clin Psychiatry. 2000;2(5):153-8. 10. Nejtek VA, Brown ES, Khan DA, Moore JJ, Van Wagner J, Perantie DC. Prevalence of mood disorders and relationship to asthma severity in patients at an inner-city asthma clinic. Ann Allergy Asthma Immunol. 2001;87(2):129-33. 11. Van Wagoner JA, Khan DA. Selective CD4+ lymphocytopenia and recalcitrant warts in an 8-year-old child. Ann Allergy Asthma Immunol. 2001;87(5):373-8. 12. Brown ES, Suppes T, Khan DA, Carmody TJ, 3rd. Mood changes during prednisone bursts in outpatients with asthma. J Clin Psychopharmacol. 2002;22(1):55-61. 13. Laurie SA, Khan DA, Gruchalla RS, Peters G. Anaphylaxis to isosulfan blue. Ann Allergy Asthma Immunol. 2002;88(1):64-6. 14. Morrison KM, Goli A, Van Wagoner J, Brown ES, Khan DA. Depressive Symptoms in Inner-City Children With Asthma. Prim Care Companion J Clin Psychiatry. 2002;4(5):174-7. 15. Coyle YM, Aragaki CC, Hynan LS, Gruchalla RS, Khan DA. Effectiveness of Acute Asthma Care Among Inner-city Adults. Arch Intern Med. 2003;163(13):1591-6. 16. Haden JR, Khan DA. Psychiatric syndromes that mimic asthma. Adv Psychosom Med. 2003;24:72-85. 17. Morgan M, Khan DA. Asthma: epidemiology, burden, and quality of life. Adv Psychosom Med. 2003;24:1-15. 18. Bolanos SH, Khan DA, Hanczyc M, Bauer MS, Dhanani N, Brown ES. Assessment of mood states in patients receiving long-term corticosteroid therapy and in controls with patient-rated and clinician-rated scales. Ann Allergy Asthma Immunol. 2004;92(5):500-5. 19. Brown ES, D JW, Frol A, Bobadilla L, Khan DA, Hanczyc M, et al. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol Psychiatry. 2004;55(5):538-45. 20. Harvey SM, Laurie S, Hilton K, Khan DA. Safety of rush immunotherapy to multiple aeroallergens in an adult population. Ann Allergy Asthma Immunol. 2004;92(4):414-9. 21. Leung DY, Nicklas RA, Li JT, Bernstein IL, Blessing-Moore J, Boguniewicz M, et al. Disease management of atopic dermatitis: an updated practice parameter. Joint Task Force on Practice Parameters. Ann Allergy Asthma Immunol. 2004;93(3 Suppl 2):S1-21. 22. Moffitt JE, Golden DB, Reisman RE, Lee R, Nicklas R, Freeman T, et al. Stinging insect : a practice parameter update. J Allergy Clin Immunol. 2004;114(4):869- 86.

David Khan, MD CV page 5 23. Morgan M, Bowers DC, Gruchalla RS, Khan DA. Safety and efficacy of repeated monthly carboplatin desensitization. J Allergy Clin Immunol. 2004;114(4):974-5. 24. Bonilla FA, Bernstein IL, Khan DA, Ballas ZK, Chinen J, Frank MM, et al. Practice parameter for the diagnosis and management of primary . Ann Allergy Asthma Immunol. 2005;94(5 Suppl 1):S1-63. 25. Brown ES, Stuard G, Liggin JD, Hukovic N, Frol A, Dhanani N, et al. Effect of phenytoin on mood and declarative memory during prescription corticosteroid therapy. Biol Psychiatry. 2005;57(5):543-8. 26. Brown ES, Vigil L, Khan DA, Liggin JD, Carmody TJ, Rush AJ. A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study. Biol Psychiatry. 2005;58(11):865-70. 27. Morgan MM, Khan DA, Nathan RA. Treatment for allergic rhinitis and chronic idiopathic urticaria: focus on oral . Ann Pharmacother. 2005;39(12):2056-64. 28. Slavin RG, Spector SL, Bernstein IL, Kaliner MA, Kennedy DW, Virant FS, et al. The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol. 2005;116(6 Suppl):S13-47. 29. Brown ES, Gan V, Jeffress J, Mullen-Gingrich K, Khan DA, Wood BL, et al. Psychiatric symptomatology and disorders in caregivers of children with asthma. Pediatrics. 2006;118(6):e1715-20. 30. Khan DA. Over-the-counter intranasal corticosteroids: empowering the patient or putting them in harm's way? Ann Allergy Asthma Immunol. 2006;96(4):506-8. 31. Shanmugam G, Schwartz LB, Khan DA. Prolonged elevation of serum tryptase in idiopathic anaphylaxis. J Allergy Clin Immunol. 2006;117(4):950-1. 32. Solis OL, Khan DA, Brown ES. Age at onset of major depression in inner-city adults with asthma. Psychosomatics. 2006;47(4):330-2. 33. Brown ES, Frol AB, Khan DA, Larkin GL, Bret ME. Impact of levetiracetam on mood and cognition during prednisone therapy. Eur Psychiatry. 2007;22(7):448-52. 34. Brown ES, Vornik LA, Khan DA, Rush AJ. Bupropion in the treatment of outpatients with asthma and major depressive disorder. Int J Psychiatry Med. 2007;37(1):23-8. 35. Buchmiller BL, Khan DA. Evaluation and management of pediatric drug allergic reactions. Curr Allergy Asthma Rep. 2007;7(6):402-9. 36. Oppedal RJ, Khan DA, Brown ES. Hypothyroidism in patients with asthma and major depressive disorder. Prim Care Companion J Clin Psychiatry. 2007;9(6):467-8. 37. Shanmugam G, Bhutani S, Khan DA, Brown ES. Psychiatric considerations in pulmonary disease. Psychiatr Clin North Am. 2007;30(4):761-80. 38. Bernstein IL, Li JT, Bernstein DI, Hamilton R, Spector SL, Tan R, et al. Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol. 2008;100(3 Suppl 3):S1- 148. 39. Brown ES, Gan V, Jeffress J, Wood BL, Miller BD, Khan DA. Antidepressant treatment of caregivers of children with asthma. Psychosomatics. 2008;49(5):420-5. 40. Brown ES, Murray M, Carmody TJ, Kennard BD, Hughes CW, Khan DA, et al. The Quick Inventory of Depressive Symptomatology-Self-report: a psychometric evaluation in patients with asthma and major depressive disorder. Ann Allergy Asthma Immunol. 2008;100(5):433-8. 41. Khan DA. Chronic urticaria: diagnosis and management. Allergy Asthma Proc. 2008;29(5):439- 46. 42. Morgan M, Khan DA. Therapeutic alternatives for chronic urticaria: an evidence-based review, Part 2. Ann Allergy Asthma Immunol. 2008;100(6):517-26; quiz 26-8, 44. 43. Morgan M, Khan DA. Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1. Ann Allergy Asthma Immunol. 2008;100(5):403-11; quiz 12-4, 68. 44. Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008;122(2 Suppl):S1-84. 45. Wierzbicki DA, Majmundar AR, Schull DE, Khan DA. Multiallergen nasal challenges in . Ann Allergy Asthma Immunol. 2008;100(6):533-7.

David Khan, MD CV page 6 46. Bhutani S, Khan DA. Allergist referrals for systemic reactions to imported fire ants: a community survey in an endemic area. Ann Allergy Asthma Immunol. 2009;102(2):145-8. 47. Dhanani K, Shanmugam G, Khan DA. A 6-year-old boy with fever and . Allergy Asthma Proc. 2009;30(6):655-9. 48. Khan DA. Allergic rhinitis with negative skin tests: does it exist? Allergy Asthma Proc. 2009;30(5):465-9. 49. Siddiqi A, Khan DA, Khan FA, Razzaq A. Therapeutic drug monitoring of amikacin in preterm and term infants. Singapore Med J. 2009;50(5):486-9. 50. Trojan T, Collins R, Khan DA. Safety and efficacy of treatment using interleukin-2 in a patient with idiopathic CD4(+) lymphopenia and Mycobacterium avium-intracellulare. Clin Exp Immunol. 2009;156(3):440-5. 51. Zubair A, Mubarik A, Jamal S, Arif A, Khan DA. Correlation of steatosis with fibrosis and necro- in chronic hepatitis C infection in the absence of confounding factors. J Coll Physicians Surg Pak. 2009;19(7):417-20. 52. Brown ES, Denniston D, Gabrielson B, Khan DA, Khanani S, Desai S. Randomized, double- blind, placebo-controlled trial of acetaminophen for preventing mood and memory effects of prednisone bursts. Allergy Asthma Proc. 2010;31(4):331-6. 53. Khan DA, Solensky R. Drug allergy. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S126-37. 54. Lieberman P, Nicklas RA, Oppenheimer J, Kemp SF, Lang DM, Bernstein DI, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol. 2010;126(3):477-80 e1-42. 55. Shakouri A, Compalati E, Lang DM, Khan DA. Effectiveness of Helicobacter pylori eradication in chronic urticaria: evidence-based analysis using the Grading of Recommendations Assessment, Development, and Evaluation system. Curr Opin Allergy Clin Immunol. 2010;10(4):362-9. 56. Swamy N, Laurie SA, Ruiz-Huidobro E, Khan DA. Successful clarithromycin desensitization in a multiple macrolide-allergic patient. Ann Allergy Asthma Immunol. 2010;105(6):489-90. 57. Tartibi HM, Majmundar AR, Khan DA. Successful use of omalizumab for prevention of fire ant anaphylaxis. J Allergy Clin Immunol. 2010;126(3):664-5. 58. Weiler JM, Anderson SD, Randolph C, Bonini S, Craig TJ, Pearlman DS, et al. Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter. Ann Allergy Asthma Immunol. 2010;105(6 Suppl):S1-47. 59. Alvares ML, Khan DA. Allergic rhinitis with negative skin tests. Curr Allergy Asthma Rep. 2011;11(2):107-14. 60. Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol. 2011;127(1 Suppl):S1-55. 61. Davis LS, Bhutani S, Barnett SR, Khan DA. Early gene expression changes with rush immunotherapy. Clin Mol Allergy. 2011;9:12. 62. Golden DB, Moffitt J, Nicklas RA, Freeman T, Graft DF, Reisman RE, et al. Stinging insect hypersensitivity: a practice parameter update 2011. J Allergy Clin Immunol. 2011;127(4):852-4 e1-23. 63. Kavosh ER, Khan DA. Second-generation H1-antihistamines in chronic urticaria: an evidence- based review. Am J Clin Dermatol. 2011;12(6):361-76. 64. Khan DA. : Historical aspects, classification, pathophysiology, clinical presentation, and laboratory diagnosis. Allergy Asthma Proc. 2011;32(1):1-10. 65. Brown ES, Howard C, Khan DA, Carmody TJ. Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study. Psychosomatics. 2012;53(1):75-80. 66. Khan DA. Cutaneous drug reactions. J Allergy Clin Immunol. 2012;130(5):1225- e6. 67. Khan DA. Exercise-induced bronchoconstriction: burden and prevalence. Allergy Asthma Proc. 2012;33(1):1-6. 68. Portnoy J, Kennedy K, Sublett J, Phipatanakul W, Matsui E, Barnes C, et al. Environmental assessment and exposure control: a practice parameter--furry animals. Ann Allergy Asthma Immunol. 2012;108(4):223 e1-15. 69. Trojan TD, Khan DA. Calcineurin inhibitors in chronic urticaria. Curr Opin Allergy Clin Immunol. 2012;12(4):412-20.

David Khan, MD CV page 7 70. Caldera-Alvarado G, Khan DA, Defina LF, Pieper A, Brown ES. Relationship between asthma and cognition: the Cooper Center Longitudinal Study. Allergy. 2013;68(4):545-8. 71. Frol AB, Vasquez A, Getahun Y, Pacheco M, Khan DA, Brown ES. A comparison of clinician- rated neuropsychological and self-rated cognitive assessments in patients with asthma and rheumatologic disorders. Allergy Asthma Proc. 2013;34(2):170-5. 72. Kao L, Rajan J, Roy L, Kavosh E, Khan DA. Adverse reactions during drug challenges: a single US institution's experience. Ann Allergy Asthma Immunol. 2013;110(2):86-91 e1. 73. Khan DA. Alternative agents in refractory chronic urticaria: evidence and considerations on their selection and use. J Allergy Clin Immunol Pract. 2013;1(5):433-40 e1. 74. Khan DA. Bringing your "A" game to urticaria and angioedema. J Allergy Clin Immunol Pract. 2013;1(5):425-6. 75. Khan DA. Treating patients with multiple drug . Ann Allergy Asthma Immunol. 2013;110(1):2-6. 76. Yoo SM, Khan DA. Implantable venous access device associated complications in patients with hereditary angioedema. J Allergy Clin Immunol Pract. 2013;1(5):524-5. 77. Bernstein JA, Lang DM, Khan DA, Craig T, Dreyfus D, Hsieh F, et al. The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol. 2014;133(5):1270-7. 78. Demoly P, Adkinson NF, Brockow K, Castells M, Chiriac AM, Greenberger PA, et al. International Consensus on drug allergy. Allergy. 2014;69(4):420-37. 79. Feldman MF, Khan DA, Brown ES, Bernstein JA. Factitious angioedema: a mimic of refractory "angioedema". J Allergy Clin Immunol Pract. 2014;2(6):795-7. 80. Gada E, Khan DA, DeFina LF, Brown ES. The relationship between asthma and self-reported anxiety in a predominantly healthy adult population. Ann Allergy Asthma Immunol. 2014;112(4):329-32. 81. Khan DA. Allergic rhinitis and asthma: epidemiology and common pathophysiology. Allergy Asthma Proc. 2014;35(5):357-61. 82. Khan DA. Reply: To PMID 24565613. J Allergy Clin Immunol Pract. 2014;2(2):240-1. 83. Malbran A, Riedl M, Ritchie B, Smith WB, Yang W, Banerji A, et al. Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial. Clin Exp Immunol. 2014;177(2):544-53. 84. Morgan M, Cooke A, Rogers L, Adams-Huet B, Khan DA. Double-blind placebo-controlled trial of dapsone in refractory chronic idiopathic urticaria. J Allergy Clin Immunol Pract. 2014;2(5):601-6. 85. Solensky R, Khan DA. Evaluation of antibiotic allergy: the role of skin tests and drug challenges. Curr Allergy Asthma Rep. 2014;14(9):459. 86. Trojan TD, Khan DA, Defina LF, Akpotaire O, Goodwin RD, Brown ES. Asthma and depression: the Cooper Center Longitudinal Study. Ann Allergy Asthma Immunol. 2014;112(5):432-6. 87. Bonilla FA, Khan DA, Ballas ZK, Chinen J, Frank MM, Hsu JT, et al. Practice parameter for the diagnosis and management of . J Allergy Clin Immunol. 2015;136(5):1186-205 e1-78. 88. Chen JR, Buchmiller BL, Khan DA. An Hourly Dose-Escalation Desensitization Protocol for Aspirin-Exacerbated . J Allergy Clin Immunol Pract. 2015;3(6):926-31 e1. 89. Har D, Patel S, Khan DA. Outcomes of using omalizumab for more than 1 year in refractory chronic urticaria. Ann Allergy Asthma Immunol. 2015;115(2):126-9. 90. Kuruvilla M, Khan DA. Anaphylaxis to drugs. Immunol Allergy Clin North Am. 2015;35(2):303- 19. 91. Park MA, Solensky R, Khan DA, Castells MC, Macy EM, Lang DM. Patients with positive skin test results to penicillin should not undergo penicillin or amoxicillin challenge. J Allergy Clin Immunol. 2015;135(3):816-7. 92. Jeon-Slaughter H, Claassen CA, Khan DA, Mihalakos P, Lee KB, Brown ES. Temporal Association Between Nonfatal Self-Directed Violence and Tree and Grass Pollen Counts. J Clin Psychiatry. 2016;77(9):1160-7. 93. Khan DA. Pharmacogenomics and adverse drug reactions: Primetime and not ready for primetime tests. J Allergy Clin Immunol. 2016;138(4):943-55.

David Khan, MD CV page 8 94. Khan DA. Hypersensitivity and immunologic reactions to biologics: opportunities for the allergist. Ann Allergy Asthma Immunol. 2016;117(2):115-20. 95. Kuruvilla M, Khan DA. Eosinophilic Drug Allergy. Clin Rev Allergy Immunol. 2016;50(2):228-39. 96. Yamamoto H, Khan DA. A 45-year-old man with shortness of breath and eosinophilia. Allergy Asthma Proc. 2016;37(3):259-62. 97. Bingemann T, Khan DA, Markovics S, Weinstein AG, Sharma HP. Feeling Burned Out? Half of Us Are: The Urgent Need to Address Provider Health and Wellness in Allergy and Immunology. J Allergy Clin Immunol Pract. 2017;5(6):1549-50. 98. Carlson SM, Kim J, Khan DA, King K, Lucarelli RT, McColl R, et al. Hippocampal volume in patients with asthma: Results from the Dallas Heart Study. J Asthma. 2017;54(1):9-16. 99. Chen JR, Khan DA. Evaluation of Penicillin Allergy in the Hospitalized Patient: Opportunities for Antimicrobial Stewardship. Curr Allergy Asthma Rep. 2017;17(6):40. 100. Chen JR, Tarver SA, Alvarez KS, Tran T, Khan DA. A Proactive Approach to Penicillin Allergy Testing in Hospitalized Patients. J Allergy Clin Immunol Pract. 2017;5(3):686-93. 101. Dykewicz MS, Wallace DV, Baroody F, Bernstein J, Craig T, Finegold I, et al. Treatment of seasonal allergic rhinitis: An evidence-based focused 2017 guideline update. Ann Allergy Asthma Immunol. 2017;119(6):489-511 e41. 102. Joshi S, Khan DA. The Expanding Field of Biologics in the Management of Chronic Urticaria. J Allergy Clin Immunol Pract. 2017;5(6):1489-99. 103. Macy E, Khan DA, Castells MC, Lang DM. Penicillin Allergy Testing: A Key Component of Antibiotic Stewardship. Clin Infect Dis. 2017;64(4):531-2. 104. Macy E, Romano A, Khan D. Practical Management of Antibiotic Hypersensitivity in 2017. J Allergy Clin Immunol Pract. 2017;5(3):577-86. 105. Patel SV, Khan DA. Adverse Reactions to Biologic Therapy. Immunol Allergy Clin North Am. 2017;37(2):397-412. 106. Raveendran R, Khan DA. Gelatin Anaphylaxis During Surgery: A Rare Cause of Perioperative Anaphylaxis. J Allergy Clin Immunol Pract. 2017;5(5):1466-7. 107. Seth S, Khan DA. The Comparative Safety of Multiple Alternative Agents in Refractory Chronic Urticaria Patients. J Allergy Clin Immunol Pract. 2017;5(1):165-70 e2. 108. Torres MJ, Romano A, Celik G, Demoly P, Khan DA, Macy E, et al. Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America. Clin Transl Allergy. 2017;7:7. 109. Abrams EM, Khan DA. Diagnosing and managing drug allergy. CMAJ. 2018;190(17):E532-E8. 110. Akula M, Kulikova A, Khan DA, Brown ES. The relationship between asthma and depression in a community-based sample. J Asthma. 2018:1-7. 111. Brown ES, Sayed N, Van Enkevort E, Kulikova A, Nakamura A, Khan DA, et al. A Randomized, Double-Blind, Placebo-Controlled Trial of Escitalopram in Patients with Asthma and Major Depressive Disorder. J Allergy Clin Immunol Pract. 2018;6(5):1604-12. 112. Chen JR, Tarver SA, Alvarez KS, Wei W, Khan DA. Improving Aztreonam Stewardship and Cost Through a Penicillin Allergy Testing Clinical Guideline. Open Forum Infect Dis. 2018;5(6):ofy106. 113. Dorman SM, Seth S, Khan DA. Risk of Allergic Reactions to Recurrent Intravenous Penicillin Administration in Penicillin Skin Test Negative Patients. J Allergy Clin Immunol Pract. 2018;6(1):196-200. 114. Jefferson AA, Khan DA, Shaker MS. The Penicillin Allergy Label: Expensive to Maintain, Inexpensive to Remove. J Allergy Clin Immunol Pract. 2018;6(3):1028-9. 115. Joshi SR, Khan DA. Effective Use of Dupilumab in Managing Systemic Allergic Contact Dermatitis. Dermatitis. 2018;29(5):282-4. 116. Khan DA, Banerji A, Elsevier. Drug allergy testing. St. Louis: Elsevier; 2018. 117. Kim JK, Har D, Brown LS, Khan DA. Recurrence of Chronic Urticaria: Incidence and Associated Factors. J Allergy Clin Immunol Pract. 2018;6(2):582-5. 118. Kroll JL, Steele AM, Pinkham AE, Choi C, Khan DA, Patel SV, et al. Hippocampal metabolites in asthma and their implications for cognitive function. Neuroimage Clin. 2018;19:213-21. 119. Maurer M, Fluhr JW, Khan DA. How to Approach Chronic Inducible Urticaria. J Allergy Clin Immunol Pract. 2018;6(4):1119-30.

David Khan, MD CV page 9 120. Wood BL, Brown ES, Lehman HK, Khan DA, Lee MJ, Miller BD. The effects of caregiver depression on childhood asthma: Pathways and mechanisms. Ann Allergy Asthma Immunol. 2018;121(4):421-7. 121. Brown ES, Kulikova A, Van Enkevort E, Nakamura A, Ivleva EI, Tustison NJ, et al. A randomized trial of an NMDA receptor antagonist for reversing corticosteroid effects on the human hippocampus. Neuropsychopharmacology. 2019;44(13):2263-7. 122. Brown ES, Sayed N, Choi C, Tustison N, Roberts J, Yassa MA, et al. A randomized, double- blind, placebo-controlled trial of lamotrigine for prescription corticosteroid effects on the human hippocampus. Eur Neuropsychopharmacol. 2019;29(3):376-83. 123. Castells M, Khan DA, Phillips EJ. Penicillin Allergy. N Engl J Med. 2019;381(24):2338-51. 124. Dorman SM, Jr., Regan SB, Khan DA. Effectiveness and safety of oral tacrolimus in refractory chronic urticaria. J Allergy Clin Immunol Pract. 2019;7(6):2033-4 e1. 125. Garvey LH, Dewachter P, Hepner DL, Mertes PM, Voltolini S, Clarke R, et al. Management of suspected immediate perioperative allergic reactions: an international overview and consensus recommendations. Br J Anaesth. 2019;123(1):e50-e64. 126. Garvey LH, Ebo DG, Kroigaard M, Savic S, Clarke R, Cooke P, et al. The use of drug provocation testing in the investigation of suspected immediate perioperative allergic reactions: current status. Br J Anaesth. 2019;123(1):e126-e34. 127. Hopkins PM, Cooke PJ, Clarke RC, Guttormsen AB, Platt PR, Dewachter P, et al. Consensus clinical scoring for suspected perioperative immediate hypersensitivity reactions. Br J Anaesth. 2019;123(1):e29-e37. 128. Khan DA, Banerji A, Bernstein JA, Bilgicer B, Blumenthal K, Castells M, et al. Cephalosporin Allergy: Current Understanding and Future Challenges. J Allergy Clin Immunol Pract. 2019;7(7):2105-14. 129. Khan DA, Knowles SR, Shear NH. Sulfonamide Hypersensitivity: Fact and Fiction. J Allergy Clin Immunol Pract. 2019;7(7):2116-23. 130. Lutfeali S, Khan DA. Pediatric Drug Allergies: Updates on Beta-Lactam, Nonsteroidal Anti- Inflammatory Drug, and Chemotherapeutic Reactions. Pediatr Clin North Am. 2019;66(5):1035- 51. 131. Mertes PM, Ebo DG, Garcez T, Rose M, Sabato V, Takazawa T, et al. Comparative epidemiology of suspected perioperative hypersensitivity reactions. Br J Anaesth. 2019;123(1):e16-e28. 132. Ritz T, Kroll JL, Patel SV, Chen JR, Yezhuvath US, Aslan S, et al. Central nervous system signatures of affect in asthma: associations with emotion-induced bronchoconstriction, airway inflammation, and asthma control. J Appl Physiol (1985). 2019;126(6):1725-36. 133. Savic LC, Khan DA, Kopac P, Clarke RC, Cooke PJ, Dewachter P, et al. Management of a surgical patient with a label of penicillin allergy: narrative review and consensus recommendations. Br J Anaesth. 2019;123(1):e82-e94. 134. Torres MJ, Adkinson NF, Jr., Caubet JC, Khan DA, Kidon MI, Mendelson L, et al. Controversies in Drug Allergy: Beta-Lactam Hypersensitivity Testing. J Allergy Clin Immunol Pract. 2019;7(1):40-5. 135. Wood RA, Khan DA, Lang DM, Fasano MB, Peden DB, Busse PJ, et al. American Academy of Allergy, Asthma and Immunology response to the EAACI/GA(2) LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of Urticaria 2017 revision. Allergy. 2019;74(2):411-3. 136. Angel DM, Zeiger RS, Sicherer SH, Khan DA, Schatz M. JACI: In Practice Response to COVID- 19 Pandemic. J Allergy Clin Immunol Pract. 2020;8(5):1475-6. 137. Demain JG, Khan DA. Penicillin Testing in Infants. J Allergy Clin Immunol Pract. 2020;8(5):1777. 138. Dykewicz MS, Wallace DV, Amrol DJ, Baroody FM, Bernstein JA, Craig TJ, et al. Rhinitis 2020: A Practice Parameter Update. J Allergy Clin Immunol. 2020. 139. Hirano I, Chan ES, Rank MA, Sharaf RN, Stollman NH, Stukus DR, et al. AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis. Gastroenterology. 2020;158(6):1776-86.

David Khan, MD CV page 10 140. Khan DA. Proactive management of penicillin and other antibiotic allergies. Allergy Asthma Proc. 2020;41(2):82-9. 141. Khan DA, Phillips EJ. Pharmacogenomic biomarkers in allergy and immunology practice. J Allergy Clin Immunol. 2020. 142. Lutfeali S, Khan DA, Wysocki C. A late preterm infant with lymphopenia. Allergy Asthma Proc. 2020;41(2):141-3. 143. Raley E, Khan DA. Drug-associated inducible laryngeal obstruction complicating penicillin allergy testing. Ann Allergy Asthma Immunol. 2020. 144. Rank MA, Sharaf RN, Furuta GT, Aceves SS, Greenhawt M, Spergel JM, et al. Technical Review on the Management of Eosinophilic Esophagitis: A Report From the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters. Gastroenterology. 2020;158(6):1789-810 e15. 145. Rank MA, Sharaf RN, Furuta GT, Aceves SS, Greenhawt M, Spergel JM, et al. Technical review on the management of eosinophilic esophagitis: a report from the AGA institute and the joint task force on allergy-immunology practice parameters. Ann Allergy Asthma Immunol. 2020;124(5):424-40 e17. 146. Schatz M, Sicherer SH, Khan DA, Zeiger RS. The Journal of Allergy and Clinical Immunology: In Practice 2019 Highlights. J Allergy Clin Immunol Pract. 2020. 147. Shaker MS, Wallace DV, Golden DBK, Oppenheimer J, Bernstein JA, Campbell RL, et al. Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020;145(4):1082-123.

.

David Khan, MD CV page 11 PUBLICATIONS

Books 1. Khan DA, Banerji A, Elsevier. Drug allergy testing. St. Louis: Elsevier; 2018.

Invited Chapters

1. Khan DA, Li JTC. Asthma in the adolescent and adult. In: Rakel RE, ed. Conn’s CurrentTherapy. 1994 ed. Philadelphia, PA: WB Saunders Co; 707-716, 1994. 2. Khan DA, Li JTC. Allergic rhinitis. In: Hurst JW, ed. Medicine for the practicing physician. 4th ed. Norwalk, CT: Appleton & Lange, 1996. 3. Khan DA, Li JTC. Allergic bronchopulmonary aspergillosis. In: Hurst JW, ed. Medicine for the practicing physician. 4th ed. Norwalk, CT: Appleton & Lange, 1996. 4. Haden, J, Khan DA. Psychiatric syndromes that mimic asthma. In: Brown ES, ed. Advances in Psychosomatic Medicine, Vol. 24:72 – 85;2003. 5. Morgan M, Khan DA. Asthma: epidemiology, burden, and quality of life. In: Brown ES, ed. Advances in Psychosomatic Medicine, Vol. 24:1 – 15;2003. 6. Shanmugam G, Bhutani S, Khan DA, Brown ES. Psychiatric considerations in pulmonary disease.Psychiatr Clin North Am. 2007 Dec;30(4):761-80. 7. Khan DA. Chronic Urticaria. In: Maibach HI, Gorouhi F ed. Evidence Based Dermatology 2nd ed. PMPH-USA. 2011 8. Khan DA. Drug Allergy. In: Adelman DC, Casale TB, Corren J eds. Manual of Allergy & Immunology 5th ed. Philadelphia, PA. Lippincott, Williams and Wilkins. 2012. 9. Khan DA. Chronic urticaria: Treatment of refractory symptoms. In UpToDate, Feldweg, AM (Ed), UpToDate, Waltham, MA, 2015. 10. Khan, DA. Chronic urticaria: Management and patient education. In: UpToDate, Feldweg, AM (Ed), UpToDate, Waltham, MA, 2015. 11. Kuruvilla ME, Khan DA. Antibiotic Allergy. In: Mandell, Douglas, Bennett eds. Principles and Practice of Infectious Diseases 8th ed. Elsevier 2015.

David Khan, MD CV page 12 PUBLICATIONS

Non-Peer Reviewed Publications (Abstracts)

1. Butterfield JH, Khan DA. Measurement of a D2 (PGD2) metabolite in urine of patients with systemic mast cell disease[Abstract]. J Allergy Clin Immunol 1994;93:227. 2. Khan DA, Gleich GJ, Kern EB, Beatty CW, Newman W, Leiferman KL. Adhesion molecule expression in the upper airway of asthmatics[Abstract]. Am J Respir Crit Care Med 1994;149: A605. 3. Richter SH, Khan DA. Rat bite anaphylaxis[Abstract]. Ann Allergy 1995;74:81. 4. Weisberg LA, Holman JM, Khan DA. Meningocoele induced rhinnorhea[Abstract]. Ann Allergy 1996;76:89. 5. Schroeder V, Khan DA, Kurt TL. Sick people and sick buildings- perceptions and problems of indoor air quality. Dallas Med J 1996;82:185-9. 6. Fawcett DD, Khan DA. Effect of a 5-lipoxygenase inhibitor on nasal polyposis[Abstract]. Ann Allergy Asthma Immunol 1998;80:116. 7. Khan DA, Brown ES, Suppes, P, Carmody TJ. Mood changes during prednisone bursts for asthma[Abstract]. Am J Respir Crit Care Med 1999;159:A919. 8. Brown ES, Khan DA, Suppes T. Treatment of corticosteroid-induced mood changes with olanzapine. Am J Psychiatry 1999;156:6. 9. Khan DA, Gruchalla RS, Millard MW, Wasserman RL, Kennerly DA. Anti-inflammatory use for persistent asthma in Dallas: Results of a Dallas Asthma Consortium DAC) survey[Abstract]. J Allergy Clin Immunol 2000;105:S317. 10. Laurie S, Khan DA. Successful clarithromycin desensitization in a macrolide sensitive patient[Abstract]. Ann Allergy Asthma Immunol 2000;84:116. 11. Laurie S, Peters G, Khan D. Anaphylaxis to isosulfan blue. Ann Allergy Asthma Immunol 2001;86:A26[Abstract]. 12. Nejtek VA, Khan DA, Brown ES. Psychiatric side effects and cognitive changeswith corticosteroids. Psychiatry Review 2001; 2: 2–3. 13. Van Wagoner J, Khan DA, Fawcett D, Marple B. Correlation of symptoms, objective measurements and quality of life in patients with nasal polyposis. J Allergy Clin Immunol 2001;107(2):A810[Abstract]. 14. Darter AL, Khan DA. Kimura’s disease presenting with eosinophilia, elevated IgE, and sepsis. Ann Allergy Asthma Immunol 2002;88:P8[Abstract] 15. Daulat SB, Khan DA. Ethanol-induced anaphylaxis with false negative challenge. Ann Allergy Asthma Immunol 2002;88:P67[Abstract]. 16. Rogers L, Khan DA. Dry Gangrene With Multiple Amputations as a Possible Complication of Common Variable Immunodeficiency. J Allergy Clin Immunol 2002;109(2):A587[Abstract]. 17. Harvey SM. Laurie S, Khan DA. Safety of Rush Desensitization to Multiple Aeroallergens in Adults. J Allergy Clin Immunol 2002;109(2):A1092[Abstract]. 18. Daulat S, Khan DA. Effectiveness and compliance amongst inner-city children with asthma prescribed montelukast. Ann Allergy Asthma Immunol 2003;90:112[Abstract]. 19. Haden J, Lumry W, Khan D. Celecoxib (Celebrex) anaphylaxis. Ann Allergy Asthma Immunol 2003;90:153[Abstract]. 20. Morgan M, Khan DA. Stinging nettle anaphylaxis. J Allergy Clin Immunol 2003;111:S98[Abstract]. 21. Haden JR, Khan DA. Remission of anaphylactoid reaction to alcohol. J Allergy Clin Immunol 2003;111:S98-9[Abstract]. 22. Darter AL, Khan DA. Pituitary macroadenoma presenting with rhinitis. J Allergy Clin Immunol 2003;111:S294[Abstract]. 23. Schmitt EJ, Khan DA. Vancomycin hypersensitivity syndrome: A case report. Ann Allergy Asthma Immunol 2004;92:166[Abstract].

David Khan, MD CV page 13 24. Morgan M, Khan DA, Gruchalla RS. Safety and efficacy of monthly carboplatin desensitization. Ann Allergy Asthma Immunol 2004;92:167[Abstract]. 25. Majmundar A, Khan D. Churg strauss syndrome presenting as peripheral lymphadenopathy. Ann Allergy Asthma Immunol 2004;92:177[Abstract]. 26. Majmundar A, Khan DA. Drug-related eosinophilia with systemic symptoms (DRESS) after successful allopurinol desensitization. Ann Allergy Asthma Immunol 2005;94:133[Abstract]. 27. Mandal B, Khan DA. Tacrolimus as a treatment for chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2005;94:189[Abstract]. 28. Ridz SL, Khan DA. Successful therapy and regression of splenomegaly in a patient with myeloproliferative hypereosinophilic syndrome (MHES) treated with imatinib. Journal of Allergy and Clinical Immunology February 2005 (Vol. 115, Issue 2 (Supplement), Page S195) [Abstract]. 29. Bhutani S, Khan D. Allergist referrals for systemic reactions to imported fire ants: A community survey in an endemic area. Journal of Allergy and Clinical Immunology February 2005 (Vol. 115, Issue 2 (Supplement), Page S99) [Abstract]. 30. Gruchalla RS, Gan V, Gimpel N, Pongdee T, Khan D, Roy LC. Community leadership in preventing asthma—CLIP asthma: Allergen sensitivity and exposure relationships in Dallas schoolchildren with asthma and asthma-like symptoms. Journal of Allergy and Clinical Immunology February 2005 (Vol. 115, Issue 2 (Supplement), Page S95) [Abstract]. 31. Majmundar A, Khan D. Successful therapy with omalizumab for imported fire ant anaphylaxis. Journal of Allergy and Clinical Immunology February 2005 (Vol. 115, Issue 2 (Supplement), Page S38) [Abstract]. 32. Ridz SL, Khan DA. Intraoperative anaphylaxis to albumin. Ann Allergy Asthma Immunol 2006;96:157[Abstract]. 33. Mandal B, Khan DA. A case of X-linked severe combine immunodeficiency presenting as erythem multiforme. Ann Allergy Asthma Immunol 2006;96:222[Abstract]. 34. Ridz SL, Khan DA. Successful Treatment of Refractory Chronic Idiopathic Urticaria with Mycophenolate Mofetil. Journal of Allergy and Clinical Immunology February 2006 (Vol. 117, Issue 2 (Supplement), Page S123) [Abstract]. 35. Mandal B, Bhushan V, Khan D. Successful Treatment Using Interleukin-2 (IL-2) in a Patient with Idiopathic CD4+ Lymphopenia (ICL) and Mycobacterium avium (M.avium). Journal of Allergy and Clinical Immunology February 2006 (Vol. 117, Issue 2 (Supplement), Page S102) [Abstract]. 36. Owen SE, Glazer C, Khan D. Steroid Myopathy Masquerading as in an Asthmatic Patient. Journal of Allergy and Clinical Immunology February 2006 (Vol. 117, Issue 2 (Supplement), Page S95) [Abstract]. 37. Khan DA. Over-the-counter intranasal corticosteroids: empowering the patient or putting them in harm's way? Ann Allergy Asthma Immunol. 2006 Apr;96(4):506-8. 38. Bhutani S, Ridz SL, Khan DA. Corticosteroid allergy to prednisone and methylprednisolone. Ann Allergy Asthma Immunol 2007;98:A51[Abstract]. 39. Wierzbicki DA, Khan DA. Successful treatment of refractory chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2007;98:A84[Abstract]. 40. Buchmiller BL, Khan DA. Safety of a single day aspirin desensitization protocol. J Allergy Clin Immunol 2007;119:S36[Abstract]. 41. Bhutani S, Wierzbicki DA, Khan DA. Factitious angioedema: a new clinical entity. Ann Allergy Asthma Immunol 2008;100:A73[Abstract]. 42. Buchmiller BL, Khan DA. Comparison of Aspirin Desensitization at Hourly Intervals Versus 3 Hour Intervals. J Allergy Clin Immunol 2008;121:S192[Abstract]. 43. Davis LS, Bhutani S, Barnett SL, Olsen NJ, Reimold A, Karp D, Khan DA. Gene Expression Profiles in Allergy and Autoimmunity. J Allergy Clin Immunol 2008;121:S82[Abstract]. 44. Bhutani S, Davis LS, Barnett SL, Khan DA. Early Changes in Gene Expression with Rush Immunotherapy. J Allergy Clin Immunol 2008;121:S124[Abstract].

David Khan, MD CV page 14 45. Shanmugam G, Mandal B, Morgan MM, Schull DE, Khan DA. Examining the Efficacy of Esomeprazole for Non-Allergic Rhinitis. J Allergy Clin Immunol 2008;121:S51[Abstract]. 46. Reddy SG, Khan DA. masquerading as multiple drug allergy. Ann Allergy Asthma Immunol 2009;102:A25[Abstract]. 47. Devora GA, de la Morena M, Khan D, Gruchalla R. CLL and EBV infection associated with mosquito bite hypersensitivity reactions. Ann Allergy Asthma Immunol 2009;102:A86[Abstract]. 48. Min DD, Bhutani S, Khan DA. Frequent spitting and post-nasal drainage in a patient with H. Pylori gastritis. Ann Allergy Asthma Immunol 2009;102:A114[Abstract]. 49. Morgan M, Khan DA. More therapeutic alternatives for chronic idiopathic urticaria? Ann Allergy Asthma Immunol 2008;101:555-6. 50. Schull D, Reddy SG, Khan DA. The Allergic Rhinitis Questionnaire (ARQ): A Valid and Reliable Measure of Symptom Severity (SS) in Allergic Rhinitis (AR). J Allergy Clin Immunol 2010;125:AB103[Abstract]. 51. Kavosh ER, Gruchalla RS, Khan DA. Retrospective Analysis of Outcomes and Safety of Drug Challenges. J Allergy Clin Immunol 2010;125:AB119[Abstract]. 52. Boos S, Khan DA. Use of Tacrolimus in the Management of Refractory Chronic Urticaria. J Allergy Clin Immunol 2010;125:AB96[Abstract]. 53. Regan SB, Khan D. Efectiveness and safety of oral tacrolimus in refractory chronic urticaria. Ann Allergy Asthma Immunol 2010;105:A19[Abstract]. 54. Clarke E, Khan DA. Short term and long term prophylaxis using a C1esterase inhibitor (C1INH) concentrate in acquired angioedema (AAE). Ann Allergy Asthma Immunol 2010;105:A62[Abstract]. 55. Paranjpe P, Khan D. Rapid oral aspirin challenge-desensitization resulting in hypotension in a patient with aspirininduced urticaria/angioedema. Ann Allergy Asthma Immunol 2010;105:A79[Abstract]. 56. Rajan, J, Khan D. Efficacy of systemic corticosteroids in drug rash with eosinophilia and systemic symptoms (DRESS) syndrome. Ann Allergy Asthma Immunol 2010;105:A84[Abstract]. 57. Clarke EE, Khan DA. Weather changes are perceived as a common trigger in asthma patients. J Allergy Clin Immunol 2011;127:AB177. 58. Regan SB, Khan DA. Prolonged use of omalizumab in refractory chronic urticaria. J Allergy Clin Immunol 2011;127:AB100. 59. Kao L, Gruchalla R, Khan D. Risk Factors for Subjective Symptoms During Drug Challenges. J Allergy Clin Immunol 2011;127:AB196. 60. Alvares M, Khan DA, Ryan MW. A Comparison of Clinical Outcomes Among Disparate Nasal Phenotypes. Ann Allergy Asthma Immunol 2012;107:A12. 61. Kao L, Khan DA. Utility and safety of immediate skin testing In anaphylaxis to trimethoprim-sulfamethoxazole. Ann Allergy Asthma Immunol 2012;107:A24. 62. Clarke E, Khan DA, Glazer C. Seronegative but positive FIPL1-PDGFRA (F/P) hypereosinophilic syndrome (HES) presenting as asthma. Ann Allergy Asthma Immunol 2012;107:A63. 63. Trojan TD, Khan DA. Succesful sirolimus therapy for severe chronic urticaria refractory to multiple alternative therapies. Ann Allergy Asthma Immunol 2012;107:A81. 64. Alvares ML, Min D, Hilton K, Walton T, Khan DA. Modifying Target Doses and Premedication Protocols Results in Less Systemic Reactions to Aeroallergen Rush Immunotherapy (RIT). J Allergy Clin Immunol 2012;129:AB194[Abstract]. 65. Clarke EE, Khan DA. Multiple Weather Related Changes Are Perceived as a Common Triggers in Inner City Asthma Patients. J Allergy Clin Immunol 2012;129:AB153[Abstract]. 66. Trojan TD, Khan DA, DeFina LF, Brown ES. Relationship between asthma and depression: the Cooper longitudinal study. Ann Allergy Asthma Immunol 2012;109:A21[Abstract]. 67. Sunny ME, Alvares ML, Hilton K, Walton T, Khan DA. Seasonal administration of rush immunotherapy Is not a risk factor for systemic reactions. Ann Allergy Asthma Immunol

David Khan, MD CV page 15 2012;109:A123[Abstract]. 68. Trojan T, Ma Y, Khan DA. Anaphylaxis Identification Using Direct and Combined ICD-9 Methods. J Allergy Clin Immunol 2013;131:AB224[Abstract]. 69. Cooke AJ, Morgan M, Rogers L, Huet-Adams B, Khan DA. Double-Blind Placebo Controlled (DBPC) Trial of Dapsone in Antihistamine Refractory Chronic Idiopathic Urticaria (CIU). J Allergy Clin Immunol 2013;131:AB143[Abstract]. 70. Khan DA. Bringing Your “A” Game to Urticaria and Angioedema. J Allergy Clin Immunol: In Practice 2013;1:425-6. 71. Kuruvilla ME, Alvares ML, Hilton K, Walton T, Khan DA. Seasonal administration of rush immunotherapy Is not a risk factor for systemic reactions. Ann Allergy Asthma Immunol 2013;111:A21[Abstract]. 72. Deol S, Khan D. A Case Of Subacute Combined Degeneration In A Patient With Common Variable Immunodeficiency. Ann Allergy Asthma Immunol 2013;111:A182[Abstract]. 73. Feldman M, Warrier, Wierzbicki D, Khan D. Factitious Angioedema: A Case Series. Ann Allergy Asthma Immunol 2013;111:A295[Abstract]. 74. Deol S, Khan DA. Intranasal Mometasone As An Alternative To Fluticasone In An HIV Patient On Ritonavir. Ann Allergy Asthma Immunol 2014;113:P154[Abstract]. 75. Kim JK, Deol S, Wysocki C, Khan DA. Successful Approach To A Patient With Multiple Drug Reactions (Including Serum Sickness) To Rituximab. Ann Allergy Asthma Immunol 2014;113:P179[Abstract]. 76. Feldman M, Khan DA. Persistence Of Penicillin Allergy Label Despite Documented Tolerance. J Allergy Clin Immunol 2014; 133:AB920[Abstract]. 77. Khan DA. Reply. J Allergy Clin Immunol Pract. 2014 Mar-Apr;2(2):240-1. 78. Dorman SM, Khan DA. Use of Tacrolimus in the Management of Refractory Chronic Urticaria. J Allergy Clin Immunol 2015; 135:AB415[Abstract]. 79. Deol S, Khan DA. Alternative Agents in Chronic Urticaria and Angioedema. J Allergy Clin Immunol 2015; 135:AB416[Abstract]. 80. Patel SV, Khan DA. Success Of Alternative Therapies In Chronic Urticaria Patients Failing Omalizumab. Ann Allergy Asthma Immunol 2015;115:A35[Abstract]. 81. Dorman SM, Khan DA, Deol S. Risk Of Re-Sensitization To Penicillins After Recurrent Intravenous Administration In Skin Test Negative Patients. Ann Allergy Asthma Immunol 2015;115:A32[Abstract]. 82. Chen JR, Tarver SA, Alvarez KS, Tran T, Khan DA. Beneficial Outcomes of an Inpatient Penicillin Allergy Testing Protocol. J Allergy Clin Immunol. 2016; 137(2):AB91 [Abstract] 83. Har D, Khan D, Kim J. Recurrent chronic urticaria: Incidence and associated factors. Annals of Allergy, Asthma & Immunology, Vol. 117, Issue 5, S3[Abstract]. 84. Chen J, Tarver S, Alvarez K, Khan D. Effects of proactive penicillin allergy testing on inpatient antibiotic utilization. Annals of Allergy, Asthma & Immunology, Vol. 117, Issue 5, S29–S30[Abstract]. 85. Joshi S, Kim JK, Saifi M, Khan DA. Modifications to Aeroallergen Rush Immunotherapy Protocols Reduces Systemic Reactions Rates. J Allergy Clin Immunol 2017;139:AB150[Abstract]. 86. Patel SV, Tarver SA, Alvarez KS, Lutek KE, Schlebus J, Khan DA. Effectiveness of Interventions to Maintain Penicillin Allergy Label Removal As Part of an Inpatient Penicillin Allergy Testing Protocol. J Allergy Clin Immunol 2017;139:AB183[Abstract]. 87. Chen JR, Tarver SA, Alvarez KS, Nguyen C, Khan DA. Reflexive penicillin allergy testing with in-hospital aztreonam use. J Allergy Clin Immunol 2017;139:AB30.[Abstract].

David Khan, MD CV page 16